Tilray (NASDAQ:TLRY) Trading Up 3.8%

Tilray Inc (NASDAQ:TLRY) shot up 3.8% on Friday . The company traded as high as $1.85 and last traded at $1.82. 10,288,998 shares were traded during trading, a decline of 64% from the average session volume of 28,861,605 shares. The stock had previously closed at $1.75.

Analyst Ratings Changes

A number of research analysts have commented on the stock. CIBC decreased their target price on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 10th. Canaccord Genuity Group dropped their target price on shares of Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Finally, Alliance Global Partners upped their price target on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday, April 5th.

Tilray Stock Up 1.7 %

The business’s fifty day moving average is $1.95 and its two-hundred day moving average is $1.94. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of -4.13 and a beta of 2.36. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11.

Hedge Funds Weigh In On Tilray

Institutional investors have recently modified their holdings of the business. Clear Street Markets LLC purchased a new position in Tilray in the third quarter valued at $25,000. Simplicity Wealth LLC acquired a new position in shares of Tilray during the first quarter worth about $28,000. RPO LLC purchased a new stake in shares of Tilray during the fourth quarter worth approximately $28,000. Lake Street Financial LLC acquired a new stake in Tilray in the third quarter valued at approximately $28,000. Finally, Great Valley Advisor Group Inc. purchased a new position in Tilray in the third quarter worth approximately $29,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.